On July 28, 2022, Concord IP2 Ltd requested the Pasithea Therapeutics Corp to call a special meeting of the shareholders and made 2 books and records demands to receive additional information regarding the Company and investigate potential actions by the board. In addition, Concord IP2 Ltd submitted a nomination notice to the Company nominating David Delaney, Avi Geller and Eric Shahinian to the Company board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.57 USD | -0.54% | -2.45% | -24.73% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.73% | 5.84M | |
+18.34% | 125B | |
+15.06% | 108B | |
-6.39% | 23.64B | |
+2.39% | 22.39B | |
-12.11% | 17.78B | |
-41.64% | 16.43B | |
-12.07% | 16.34B | |
+1.05% | 13.56B | |
+25.87% | 11.59B |
- Stock Market
- Equities
- KTTA Stock
- News Pasithea Therapeutics Corp.
- Concord IP2 Ltd Nominates Candidates to the Board of Pasithea Therapeutics Corp